Compare OSRH & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | OSRH | ALUR |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 18.9M |
| IPO Year | N/A | N/A |
| Metric | OSRH | ALUR |
|---|---|---|
| Price | $0.52 | $1.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | ★ 3.1M | 110.4K |
| Earning Date | 04-22-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $0.95 |
| 52 Week High | $11.30 | $5.94 |
| Indicator | OSRH | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 39.46 | 37.79 |
| Support Level | $0.49 | $1.04 |
| Resistance Level | $0.58 | $1.41 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 8.84 | 24.64 |
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.